Surrogate Mother Gives Birth To Baby With Heart Defect

When the ultrasound tech went quiet at 20 weeks, everyone in the room felt it. The surrogate shifted on the table. The intended parents stopped breathing. And the doctor — measured, careful — said the words no one wants to hear: "There's an abnormality in the fetal heart.

" That moment changes everything. Not just for the people in that room, but for the legal agreements, the medical plans, the emotional architecture holding a surrogacy journey together. In 2026, with prenatal diagnostics sharper than ever and surrogacy more common across more states and countries, this scenario plays out more often than most people realize. What Happens When a Fetal Heart Defect Is Diagnosed During Surrogacy A fetal heart defect — congenital heart disease, or CHD — means the baby's heart didn't form quite right.

Could be a hole between chambers. A valve that's too narrow. A vessel connected to the wrong place. Some are minor, barely a blip.

Others are complex, requiring surgery within days of birth. In a traditional pregnancy, the parents process this news together with their OB and a pediatric cardiologist. In surrogacy, there's a third person in the equation. The surrogate carries the pregnancy.

The intended parents hold the legal rights (usually). And the medical decisions? That's where it gets complicated. Most gestational carrier agreements include clauses about "selective reduction" or "termination for medical reasons.

" But a heart defect at 20 weeks isn't always a clear-cut case. Survival rates for many CHDs now exceed 90% with proper surgical care. The baby isn't "non-viable. " The question becomes: what level of medical complexity are the intended parents prepared for?

And what does the surrogate's contract actually say about continuing a pregnancy with known anomalies? Why This Moment Tests Every Agreement Surrogacy contracts are drafted months before transfer. They cover compensation, travel, C-section provisions, even breast milk pumping. But the "anomaly clause" — the paragraph addressing fetal abnormalities — is often vague, copied from a template, or written for worst-case scenarios like trisomy 13 or anencephaly.

A heart defect sits in a gray zone. Some contracts give intended parents sole decision-making authority. Others require mutual agreement. A few — especially in states with strong surrogate protections — give the carrier final say on whether to continue the pregnancy.

If the contract doesn't specify, state law fills the gap. And state laws vary wildly. In California, intended parents typically hold decision-making power once parentage is established. In New York, the surrogate retains bodily autonomy throughout.

In Texas, the gestational agreement must be validated by a court before* transfer, and its terms govern. Internationally? Even messier. Ukraine, Georgia, Colombia — each has different frameworks, and many don't address fetal anomalies explicitly.

The practical result: when that 20-week anatomy scan shows a ventricular septal defect or tetralogy of Fallot, the lawyers get called before the cardiologists finish explaining the prognosis. How the Medical Workup Actually Works Let's say the anatomy scan flags something. What happens next? Fetal echocardiogram — the real picture A standard ultrasound sees four chambers.

A fetal echo sees flow, pressure gradients, valve function, great vessel anatomy. It's performed by a pediatric cardiologist or a maternal-fetal medicine specialist with advanced cardiac training. This isn't a 15-minute scan. It can take 45 to 90 minutes.

The results classify the defect: simple, moderate, or complex. Simple might be a small VSD (ventricular septal defect) that closes on its own. Moderate could be coarctation of the aorta — needs surgery, but outcomes are excellent. Complex means single-ventricle physiology, requiring staged surgeries (Norwood, Glenn, Fontan) over the first few years of life.

Genetic workup — because hearts don't exist in isolation CHD associates with chromosomal abnormalities in 12–15% of cases. 22q11.2 deletion (DiGeorge syndrome). Trisomy 21, 18, 13. Turner syndrome.

Noonan syndrome. In 2026, non-invasive prenatal testing (NIPT) from maternal blood catches most of these — but not all. Microdeletions and single-gene disorders need amniocentesis with chromosomal microarray. If the surrogate's blood is used for NIPT, the fetal fraction comes from her circulation.

Read more: Man City Face Inter Milan in Pre-season Friendly and Wings vs Mystics: WNBA Picks for Friday.

That works fine. But if there's any question about mosaicism or confined placental mosaicism, amnio gives the definitive fetal karyotype. Multidisciplinary counseling — the meeting that matters Best practice in 2026: a joint session with pediatric cardiology, cardiac surgery, neonatology, genetics, MFM, social work, and — critically — both the surrogate and intended parents. Together.

Same room. Same facts. This is where the medical reality meets the human reality. The surgeon explains the likely procedures, timing, ICU stays, long-term neurodevelopmental outcomes.

The geneticist explains recurrence risks (low for most isolated CHDs, higher if a syndrome is found). The social worker outlines NICU logistics, insurance coordination, discharge planning. The surrogate hears what her body will go through: possible preterm delivery, C-section, recovery while the baby is in the cardiac ICU. The intended parents hear what their child's first year might look like: surgeries, feeding tubes, developmental follow-up, lifelong cardiology care.

Common Mistakes / What Most People Get Wrong Assuming the contract covers this. Most don't — not specifically. "Major fetal anomaly" is not the same as "moderate CHD with 95% surgical survival. " Ambiguity breeds conflict.

Thinking the surrogate's feelings are secondary. She's the one carrying the pregnancy. She feels the kicks. She faces the delivery risks.

Her emotional investment is real, even in gestational surrogacy where there's no genetic link. Dismissing that is how lawsuits happen. Believing "everything will be fine" or "it's a disaster" without data. CHD outcomes have improved dramatically.

A baby born with transposition of the great arteries in 2026 has a fundamentally different prognosis than one born in 2006. Decisions need current numbers, not outdated fears. Forgetting insurance. The baby's coverage depends on the intended parents' plan — but the surrogate's delivery is covered by her insurance or the intended parents' policy per contract.

NICU stays for cardiac babies average $200K–$1.5M. Who pays if the baby needs ECMO? The contract should say. Often it doesn't.

Not planning for the "what if we disagree" scenario. Mediation clauses help. So does naming a neutral third-party physician advisor in the contract. Without these, you're in court — fast, expensive, and public.

Practical Tips / What Actually Works Rewrite the anomaly clause before transfer. Not after. Sit down with reproductive law counsel and specify: what categories of findings trigger what decision-making process? Define "lethal," "severe," "moderate," "mild" with medical benchmarks, not adjectives.

Include a mandatory multidisciplinary conference clause. Require that any fetal anomaly diagnosis triggers a joint counseling session with defined specialists before any decision deadline. Address the surrogate's autonomy explicitly. Does she have veto power over termination?

Over continuation? Over invasive procedures (amnio, fetal surgery)? Spell it out. Ambiguity helps no one.

Coordinate insurance before pregnancy. * Confirm the intended parents' plan covers congenital heart surgery at a top-tier pediatric cardiac center. Verify network status for the likely delivery hospital and children's hospital. Get it in writing.

Build a relationship before the crisis. Surrogates and intended parents who meet regularly, share updates, attend appointments together — they manage bad news better. Trust isn't built in the ultrasound room. It's built in the months before.

Know your pediatric cardiac center options.